Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Opiant Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q2 2022
- Shares held
- 1.81M
- −58.7K (−3.2%) vs. Q2 2022
- Total value
- $19.4M
- −$2.94M (−13.2%) vs. Q2 2022
- New holders
- 3
- 10 more added
- Sold out
- 4
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| National Bank of Canada | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 180 | $1.94K | 0.00% | 00.0% | Unchanged |
| American Research & Management Co. | 300 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 434 | $4.00K | 0.00% | −935−68.3% | Reduced |
| Lindbrook Capital, LLC | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,233 | $13.0K | 0.00% | −167−11.9% | Reduced |
| UBS Group AG | 1,446 | $16.0K | 0.00% | +266+22.5% | Added |
| Advisor Group Holdings, Inc. | 5,800 | $62.0K | 0.00% | +300+5.5% | Added |
| Morgan Stanley | 7,211 | $77.0K | 0.00% | −1,546−17.7% | Reduced |
| Susquehanna Fundamental Investments, LLC | 10,052 | $108.0K | 0.00% | +10,052 | New |
| Trexquant Investment LP | 13,219 | $142.0K | 0.00% | +1,000+8.2% | Added |
| State Street Corp | 13,285 | $143.0K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 13,550 | $146.0K | 0.00% | +13,550 | New |
| Mesirow Financial Investment Management, Inc. | 17,633 | $190.0K | 0.90% | +17,633 | New |
| Bank of New York Mellon Corp | 17,796 | $191.0K | 0.00% | +117+0.7% | Added |
| Two Sigma Investments, LP | 21,730 | $234.0K | 0.00% | −15,326−41.4% | Reduced |
| Two Sigma Advisers, LP | 23,400 | $252.0K | 0.00% | −51,000−68.5% | Reduced |
| Perritt Capital Management Inc | 30,500 | $328.0K | 0.21% | 00.0% | Unchanged |
| Northern Trust Corp | 38,924 | $418.0K | 0.00% | +1,498+4.0% | Added |
| BlackRock Inc. | 39,922 | $429.0K | 0.00% | +127+0.3% | Added |
| Essex Investment Management Co LLC | 47,169 | $507.0K | 0.08% | −3,236−6.4% | Reduced |
| Geode Capital Management, LLC | 48,727 | $523.0K | 0.00% | +167+0.3% | Added |
| Parkman Healthcare Partners LLC | 76,530 | $823.0K | 0.23% | +898+1.2% | Added |
| Dimensional Fund Advisors LP | 112,492 | $1.21M | 0.00% | −14,800−11.6% | Reduced |
| Acadian Asset Management LLC | 126,978 | $1.36M | 0.01% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 152,278 | $1.64M | 0.74% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 176,915 | $1.90M | 0.00% | −16,500−8.5% | Reduced |
| Vanguard Group Inc | 187,158 | $2.01M | 0.00% | 00.0% | Unchanged |
| Apis Capital Advisors, LLC | 204,000 | $2.19M | 3.29% | +8,000+4.1% | Added |
| Wells Fargo & Company | 205,117 | $2.21M | 0.00% | +1,886+0.9% | Added |
| HealthInvest Partners AB | 210,000 | $2.26M | 4.77% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,044−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −384−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −266−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −20−100.0% | Sold out |